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E-mail address: sureshbabuvommina@rediffmail.cAn efﬁcient protocol for the synthesis of a new series of dithiocarbamate-linked peptidomimetics is
described. The in situ generated dithiocarbamic acid intermediate formed by the reaction of an amino
acid ester and carbon disulﬁde in the presence of triethylamine was treated with N-protected amino alkyl
iodide to afford title compounds 3a–g in good to moderate yields. The synthesis of N-Fmoc-protected tri-
peptidomimetics 4a–e containing two dithiocarbamate linkages is also described. The protocol was fur-
ther extended to synthesize N,N0-orthogonally protected dithiocarbamate-linked dipeptidomimetics 7a–
c as well. The mild reaction conditions and non-toxic reagents are the advantages of the present method.
 2009 Elsevier Ltd. All rights reserved.Natural peptides have been the potent source of lead com-
pounds in drug discovery albeit with limited utility due to their
poor pharmacokinetic properties, rapid metabolism and low bio-
availability.1,2 Hence a variety of peptide mimics are being devel-
oped to introduce drug-like character along with increased po-
tency, target speciﬁcity and longer duration of action. To this
end, several classes of peptidomimetics are tailored by replacing
the native amide bond with various other tethers and are biologi-
cally scrutinized.3 Our group has been involved in developing efﬁ-
cient methods for the synthesis of peptidomimetics by inserting
non-native linkages such as urea,4 thiourea,5 retro-amide,6 carba-
mate7 and heterocycles.8 Recently, we turned our attention to-
wards another useful and biologically important functionality
namely dithiocarbamate.9 Reports in the literature demonstrate
that the dithiocarbamate containing molecules show antibacterial,
anthelmintic, anti-cancer, fungicidal and growth depressant prop-
erties.10,11 The utility of dithiocarbamate group as linkers in solid
phase organic synthesis12,13 and in certain photochemical applica-
tions14 is also well documented. The dithiocarbamate functionality
chelates heavy metals that make them versatile ligands,15 and are
applicable as NO scavengers. Furthermore, the functionalized
dithiocarbamates such as benzamide-based thiocarbamates have
been developed as HIV-I NCp7 inhibitors.16
Earlier approaches for the synthesis of dithiocarbamate esters
employed the reaction of an amine with expensive and toxic re-
agents such as thiophosgene and its derivatives.17 Synthesis of
substituted dithiocarbamates is carried out by a reaction of aminell rights reserved.
986312937.
om (V.V. Sureshbabu).and carbon disulﬁde (CS2) on electron-deﬁcient alkene throughMi-
chael-type reaction in the presence of a base or solid alkaline
Al2O3.18 Ranu et al., recently described a one-pot three-component
condensation of an amine, CS2 and an activated alkene in an ionic
liquid.19 Villa and co-workers, synthesized bis(dithiocarbamate)
derivatives of glycerol through a multi-step process and have dem-
onstrated their antifungal activity.20 A similar chemistry was fol-
lowed by Raﬁn and co-workers21 for the synthesis of
dithiocarbamate derivatives of carbohydrate conjugates. A three-
component reaction employing Cs2CO3, tetrabutylammonium io-
dide (TBAI) and CS2 for a reaction between an amine and a substi-
tuted halide was reported by Jung and co-workers22 Strong bases
such as anhydrous potassium phosphate have also been used for
the reaction of an amine and CS2 with electrophilic alkenes to ob-
tain corresponding dithiocarbamate compounds.23 While a one-
pot synthesis of dithiocarbamates starting from corresponding
alcohols using Mitsunobu reagent was developed by Chaturvedi
and Ray,24 benzotriazole-assisted synthesis of dithiocarbamates
by a reaction of S-nucleophiles with thiocarbonylbenzotriazoles
was developed by Katritzky’s group.25 Saidi and co-workers have
described a straightforward catalyst-free one-pot synthesis of
dithiocarbamates under solvent-free conditions.26,27 The same
group has also demonstrated a Michael-type reaction between an
amine, CS2 with a,b-unsaturated compounds in water.28 Dithiocar-
bamate preparation by a reaction between an epoxide, amine and
CS2 in one-pot fashion is also known.29
A thorough literature survey revealed that the dithiocarbamate-
linked peptidomimetics are yet to be reported. In correlation with
other non-amide tethers such as ureas and carbamates, incorpora-
tion of dithiocarbamate into peptide backbone may result in
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Scheme 1. Synthesis of dithiocarbamates 3a–g.
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earlier by Salvatore et al.,22 we, in the present Letter report a sim-
ple synthesis of dithiocarbamate-linked peptidomimetics by a
reaction of CS2 with suitably chosen amino acid derived amine
and halide components in the presence of triethylamine (TEA).
The reaction between carbon disulﬁde and an N-nucleophile in-
volves addition of CS2 to NH bonds. It results in dithiocarbamate
salt that can be transformed into various intermediates and prod-
ucts such as isothiocyanates. Recently, we reported the preparation
of N-protected amino alkyl isothiocyanates employing CS2 and
TEA.5 During this study, it was envisaged that the intermediate
dithiocarbamic acid salts react with electron-deﬁcient carbon cen-Table 1
List of dithiocarbamate tethered peptidomimetics 3
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Otres such as alkyl halides to afford respective class of dithiocarba-
mate compounds. This chemistry was explored to prepare new
classes of peptidomimetics and the results are discussed here.
Our ﬁrst target was a dipeptidomimetic of the type 3. This was
accomplished by a reaction of an amino acid ester, CS2, TEA and
N-protected amino alkyl iodide. The iodo intermediates used in
the present studies were prepared by following a reported proto-
col.30 Brieﬂy, an N-protected amino acid was reduced into corre-
sponding aminol and the hydroxy group was subjected to
Mitsunobu reaction using PPh3, imidazole and iodine to afford cor-
responding N-protected amino alkyl iodide 1. In a typical reaction,
the preparation of compounds 3 involved ﬁrst treatment of a½a25D  c 1, CHCl3 Yield (%) HRMS obsd/calcd
44.6 72 585.1831
(585.1858)
52.7 74 523.1698
(523.1701)
38.1 65 567.1429
(567.1422)
110.1 68 665.1583
(665.1578)
19.8 70 469.1222
(469.1232)
+17.5 69 483.1394
(483.1388)
+9.0 62 670.2380
(670.2385)
Comp. 
No.  
R1 R2 R3 [ ]25D 
c 1, 
CHCl3
Yield 
(%) 
4a CH(CH3)2 CH2C6H5 CH3 -78.7 58 
4b CH3 CH2CH(CH3)2 CH2C6H5 -32.0 61 
4c H (CH2)2SCH3 CH(CH3)2 +11.8 55 
4d -(CH2)3- (CH2)2SCH3 CH2CH(CH3)2 -85.2 60 
4e CH3 CH2CH(CH3)2 CH(CH3)CH2
CH3
-74.6 53 
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Scheme 2. Synthesis of dithiocarbamate-linked tripeptidomimetics through N-terminal elongation.
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Table 2
Dithiocarbamate-linked dipeptidomimetics 7, 8
Compd No. Dithiocarbamates ½a25D  c 1, CHCl3 Yield (%) HRMS obsd (calcd)
7a
BocNH
H
N S
HNFmoc
Ph
S
46.8 72 670.2757
(670.2749)
7b ZNH
H
N S
HNFmoc
S
19.3 68 614.2119
(614.2123)
7c
FmocNH
H
N S
HNZ
S
12.7 65 614.2133
(614.2123)
8a
BocNH
H
N S COOMe
Ph
S
+29.7 62 421.1230
(421.1232)
8b FmocNH
H
N S COOEt
S
+33.5 67 481.1220
(481.1232)
8c
ZNH
H
N S COOMe
S
8.2 70 421.1229
(421.1232)
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This was followed by the addition of a solution of N-Fmoc-Val-
W[CH2–I]. The reaction was complete in about an hour as adjudged
by TLC. A simple work-up followed by column chromatography
yielded pure N-protected dithiocarbamate-linked dipeptidomi-
metic 3a in 72% yield (Scheme 1).31 The generality of this reaction
was demonstrated with a series of N-Fmoc/Z-amino alkyl iodides
and amino acid esters to afford the corresponding dipeptidomi-
metics 3b–g in good to moderate yields (Table 1). The products
were found to be analytically pure and the protocol was racemiza-
tion free as evident by HPLC and NMR analyses.32
In the subsequent study, the chain elongation of dipeptidomi-
metics 3 on N-terminal was undertaken to synthesize tripeptidom-
imetics containing two dithiocarbamate linkages in the backbone.
Starting with 3a, the amine was deprotected using 50% diethyl-
amine (DEA) in CH2Cl2 and the resulting amino-free dipeptidomi-
metic was reacted with CS2, TEA and N-Fmoc-Ala-w[CH2–I] 1 to
afford N-Fmoc-tripeptidomimetic 4a possessing two dithiocarba-
mate groups (Scheme 2). Employing this protocol, four more
dithiocarbamate-linked tripeptidomimetics 4b–e were prepared
and isolated successfully that were adequately characterized.33
Finally, the protocol was further explored to describe two other
types of dithiocarbamate-linked peptidomimetics starting from N-
protected amino acid derived vicinal diamines 5. The required N-
protected amino alkyl amines 5 were synthesized using known
protocol. N-Fmoc amino alkyl amines34 were prepared by reducing
the corresponding alkyl azides under catalytic hydrogenation,
while N-Boc and N-Z-amino alkyl amines were synthesized by
LiAlH4-mediated reduction of their nitriles.5 Then a reaction of 5
with CS2 in the presence of TEA gave the corresponding dithiocar-
bamic acid intermediate which without isolation, was treated with
either N-protected amino alkyl iodide 1 or bromo acetic acid ester
6 to afford dithiocarbamate-linked orthogonally protected dipepti-
domimetics 7a–c and simple dipeptidomimetics 8a–c, respectively
(Scheme 3, Table 2). All the compounds were isolated after a sim-
ple work-up as gummy solids and fully characterized using mass
and NMR spectroscopic techniques.
In conclusion, we report a simple and mild protocol for the syn-
thesis of a new class of dithiocarbamate-linked peptidomimetics
using CS2, TEA and corresponding amines and appropriate halides.
The reaction is fast, high yielding and is devoid of the use of toxic
reagents. The protocol is racemization free and all the synthesized
compounds were isolated and well characterized.Acknowledgements
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